2/10/2014 10:14:33 AM
ST. LOUIS--(BUSINESS WIRE)--Mallinckrodt (NYSE: MNK) today announced the commercial launch of PENNSAID® (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%). PENNSAID 2% is a topical non-steroidal anti-inflammatory drug (NSAID) approved for use in the treatment of the pain of osteoarthritis of the knees.
Help employers find you! Check out all the jobs and post your resume.
comments powered by